Table 1. Basic data for all included studies in the meta-analysis.
| First author | Year | Country | Cohort sample size | Cancer type (derived) | Detection method | HULC expression | Survival | quality score | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Low/ high | Low | High | Variance Analysis | Outcomes | |||||||||||
| LNM | DM | Recurrence | LNM | DM | Recurrence | ||||||||||
| Uzan VR, et al | 2016 | Brazil | 33 | Osteosarcoma (tissue) | RT-PCR | 21/12 | NR | NR | NR | NR | NR | NR | Univariate | OS, EFS | 7 |
| Yang Z, et al. | 2015 | Korea | 240 | Hepatocellular Carcinoma (tissue) | RT-PCR | NR | NR | NR | NR | NR | NR | NR | Multivariateanalysis | OS, DFS | 7 |
| Sun XH, et al. | 2015 | China | 78 | Osteosarcoma (tissue) | RT-PCR | 39/39 | NR | 5/34 | NR | NR | 16/23 | NR | Multivariateanalysis | OS | 7 |
| Li SP, et al. | 2016 | China | 38 | Hepatocellular Carcinoma (tissue) | RT-PCR | 15/23 | NR | 1/14 | 5/10 | NR | 8/15 | 16/7 | Univariate | OS | 7 |
| Jin C, et al. | 2016 | China | 54 | gastric cancer (serum) | RT-PCR | 27/27 | 25/27 | 2/50 | NR | 34/14 | 9/39 | NR | Univariate | OS | 7 |
| Peng W, et al. | 2014 | China | 304 | pancreatic cancer (tissue) | RT-PCR | 92/212 | 23/69 | NR | 79/13 | 157/55 | NR | 208/4 | Multivariateanalysis | OS | 8 |
| Peng W, et al. | 2016 | China | 142 | Diffuse large B-cell lymphoma (lymph node) | RT-PCR | 47/95 | NR | NR | NR | NR | NR | NR | Multivariateanalysis | OS, PFS | 8 |
| Zhang Y, et al. | 2016 | China | 42 | gastric cancer (serum) | RT-PCR | 20/22 | NR | NR | NR | NR | NR | NR | Univariate | OS | 8 |
| Yang XJ, et al. | 2016 | China | 35 | colorectal carcinoma (tissue) | RT-PCR | 12/23 | NR | NR | NR | NR | NR | NR | Univariate | OS | 8 |
Abbreviations: LNM, lymph node metastasis; DM, distant metastasis; OS, overall survival; DFS, disease-free survival; EFS, event-free survival; PFS, progression-free survival; NR, no report